Kyfil 60mg Injection is an anticancer medication containing the active constituent Carfilzomib.
It is used to treat multiple myeloma, a cancer of plasma cells that grow uncontrollably and accumulate in the bone marrow, damaging the bones and kidneys.
Uses:
Treatment of multiple myeloma.
Therapeutic Effects:
Kyfil 60mg Injection is a proteasome inhibitor. It works by blocking the action of proteasomes, the enzymes responsible for breaking down proteins in cells.
By blocking proteasomes, this medication can prevent the growth and survival of cancer cells, leading to their death.
This can help to slow or stop the progression of multiple myeloma and may improve survival rates for some patients.
Interaction with other drugs:
Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Kyfil 60mg Injection and reduce effectiveness by causing undesirable side effects.
Storage:
Store Kyfil 60mg Injection under refrigeration between 2°C to 8°C (36°F to 46°F).
Keep it in the original package until it is ready to use.
Do not freeze.
Discard any unused portion after 4 hours.
Keep out of reach of children and pets.
Administration:
Kyfil 60mg Injection is typically administered as an intravenous (IV) injection in a hospital or clinical setting by a healthcare provider.
The exact dosing and frequency of administration will depend on the specific condition being treated and other individual factors, such as the patient's age, weight, and overall health.
If a dose is missed, contact your healthcare provider as soon as possible.
Safety Advices:
Pregnancy: Kyfil 60mg Injection is unsafe for pregnant women as it may cause fetal harm.
Breastfeeding: It is unknown whether Kyfil 60mg Injection is excreted in human breast milk. So breastfeeding mothers should consult a doctor before taking it.
Lungs: Kyfil 60mg Injection can cause lung-related side effects, such as shortness of breath, coughing, and pulmonary hypertension.
Liver: There is limited information on the use of Kyfil 60mg Injection in patients with severe liver impairment, and caution is advised in this population.
Alcohol: There is limited information on the interaction between alcohol and Kyfil 60mg Injection. However, it is generally recommended to avoid or limit alcohol consumption during treatment.
Driving: Kyfil 60mg Injection may cause side effects such as fatigue, dizziness, or blurred vision that can impair a patient's ability to drive or operate machinery safely.
Side Effects:
Serious: Cardiac events such as heart failure, heart attack, or arrhythmias; blood clotting disorders or bleeding; acute kidney injury; lung damage or inflammation; infections; tumor lysis syndrome.
Common: Fatigue, nausea and vomiting, diarrhea, low blood cell counts (anemia, low white blood cell count, low platelet count), fever, headache, difficulty breathing or shortness of breath, cough, muscle weakness or pain, rash, back pain.
FAQs:
Q 1. Can Kyfil 60mg Injection be used in combination with other cancer treatments?
Yes, Kyfil 60mg Injection is often combined with other cancer treatments, such as chemotherapy or immunotherapy.
Q 2. Can Kyfil 60mg Injection cure multiple myeloma?
While Kyfil 60mg Injection is an effective treatment for multiple myeloma, it is not considered a cure.
Q 3. Can I take over-the-counter medications while on Kyfil 60mg Injection?
It is important to consult with your healthcare provider before taking any over-the-counter medications while on Kyfil 60mg Injection, as some may interact with the treatment and affect its effectiveness.
Q 4. Will I lose my hair during treatment with Kyfil 60mg Injection?
Hair loss is not a common side effect of Kyfil 60mg injection treatment.
Q 5. Can I take Kyfil 60mg Injection if I have tuberculosis?
Kyfil 60mg Injection is generally not recommended for use in patients with an active infection, including tuberculosis.
